Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Schrader

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Haematologica|February 5, 2021
Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathwaysTill Braun, Markus Glass, Linus Wahnschaffe, et al.
International Journal of Cancer|September 14, 2011
High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomasAlexandra Schrader, Stefan Bentink, Rainer Spang, et al.
Blood|March 18, 2011
Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomasKaterina Vrzalikova, Martina Vockerodt, Sarah Leonard, et al.
Cancers|May 13, 2023
The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLLMoritz Otte, Johanna Stachelscheid, Markus Glaß, et al.
Cell Communication and Signaling : CCS|December 21, 2012
Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomasAlexandra Schrader, Katharina Meyer, Frederike von Bonin, et al.
Molecular Cancer|June 5, 2015
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burdenChristian Prinz, Elena Vasyutina, Gregor Lohmann, et al.
Cancer Research|March 8, 2022
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic LeukemiaTill Braun, Johanna Stachelscheid, Nadine Bley, et al.
Cancers|November 27, 2019
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLLinus Wahnschaffe, Till Braun, Sanna Timonen, et al.
Leukemia & Lymphoma|September 21, 2018
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenanceNatali Pflug, Paula Cramer, Sandra Robrecht, et al.
Oncotarget|May 12, 2016
Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression dataAlexandra Schrader, Katharina Meyer, Neele Walther, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Haematologica|February 5, 2021
Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathwaysTill Braun, Markus Glass, Linus Wahnschaffe, et al.
International Journal of Cancer|September 14, 2011
High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomasAlexandra Schrader, Stefan Bentink, Rainer Spang, et al.
Blood|March 18, 2011
Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomasKaterina Vrzalikova, Martina Vockerodt, Sarah Leonard, et al.
Cancers|May 13, 2023
The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLLMoritz Otte, Johanna Stachelscheid, Markus Glaß, et al.
Cell Communication and Signaling : CCS|December 21, 2012
Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomasAlexandra Schrader, Katharina Meyer, Frederike von Bonin, et al.
Molecular Cancer|June 5, 2015
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burdenChristian Prinz, Elena Vasyutina, Gregor Lohmann, et al.
Cancer Research|March 8, 2022
Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic LeukemiaTill Braun, Johanna Stachelscheid, Nadine Bley, et al.
Cancers|November 27, 2019
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLLinus Wahnschaffe, Till Braun, Sanna Timonen, et al.
Leukemia & Lymphoma|September 21, 2018
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenanceNatali Pflug, Paula Cramer, Sandra Robrecht, et al.
Oncotarget|May 12, 2016
Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression dataAlexandra Schrader, Katharina Meyer, Neele Walther, et al.
Pageof 3